Bids for Indian pharma giant turn hostile
The acquisition of India’s biggest drug maker, Ranbaxy, by Japanese pharmaceutical company, Daiichi Sankyo, has been thrown into some doubt amid rumours of a hostile takeover bid for the generic company from Pfizer.
The agreement, made last week…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.